rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Christobel Selecky

Director

Company insider

Files Form 4 as: Director, ImmunityBio.

Every Form 4 they filed

In numbers

Trades disclosed
60
Buys
0
Sells
6
Bought
$0
Sold
$6.0M
Companies
1
Companies where not an officer
1
First trade
3 May 2021
Last trade
1 Jul 2026
Last filed
6 Jul 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
IBRX ImmunityBioDirector · Biotechnology · last 1 Jul 20260 buys · 6 sells

Activity over time

1 Jan – 1 Oct
30Jan 26Mar 26Jun 26Aug 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
1 Jul 2026filed 6 Jul 2026IBRX ImmunityBioBiotechnologySEC FORM 4 Code M$104K35,064 at $2.98filing
1 Jul 2026filed 6 Jul 2026IBRX ImmunityBioBiotechnologySEC FORM 4 Code M$372K124,414 at $2.99filing
1 Jul 2026filed 6 Jul 2026IBRX ImmunityBioBiotechnologySEC FORM 4 Sold$1.4M159,478 at $9.02filing
1 Jul 2026filed 6 Jul 2026IBRX ImmunityBiooption or derivative · BiotechnologySEC FORM 4 Code M—35,064 at $0.00filing
1 Jul 2026filed 6 Jul 2026IBRX ImmunityBiooption or derivative · BiotechnologySEC FORM 4 Code M—124,414 at $0.00filing
1 Jul 2026filed 6 Jul 2026IBRX ImmunityBiooption or derivative · BiotechnologySEC FORM 4 Code M—35,064 at $0.00filing
1 Jul 2026filed 6 Jul 2026IBRX ImmunityBiooption or derivative · BiotechnologySEC FORM 4 Code M—124,414 at $0.00filing
1 Jul 2026filed 6 Jul 2026IBRX ImmunityBioBiotechnologySEC FORM 4 Code M$104K35,064 at $2.98filing
1 Jul 2026filed 6 Jul 2026IBRX ImmunityBioBiotechnologySEC FORM 4 Code M$372K124,414 at $2.99filing
1 Jul 2026filed 6 Jul 2026IBRX ImmunityBioBiotechnologySEC FORM 4 Sold$1.4M159,478 at $9.02filing
30 Jun 2026filed 1 Jul 2026IBRX ImmunityBiooption or derivative · BiotechnologySEC FORM 4 Code M—700 at $0.00filing
30 Jun 2026filed 1 Jul 2026IBRX ImmunityBiooption or derivative · BiotechnologySEC FORM 4 Code M—300 at $0.00filing
30 Jun 2026filed 1 Jul 2026IBRX ImmunityBiooption or derivative · BiotechnologySEC FORM 4 Code M—700 at $0.00filing
30 Jun 2026filed 1 Jul 2026IBRX ImmunityBiooption or derivative · BiotechnologySEC FORM 4 Code M—300 at $0.00filing
30 Jun 2026filed 1 Jul 2026IBRX ImmunityBioBiotechnologySEC FORM 4 Code M$2,086700 at $2.98filing
30 Jun 2026filed 1 Jul 2026IBRX ImmunityBioBiotechnologySEC FORM 4 Code M$897300 at $2.99filing
30 Jun 2026filed 1 Jul 2026IBRX ImmunityBioBiotechnologySEC FORM 4 Sold$9,0001,000 at $9.00filing
30 Jun 2026filed 1 Jul 2026IBRX ImmunityBioBiotechnologySEC FORM 4 Code M$2,086700 at $2.98filing
30 Jun 2026filed 1 Jul 2026IBRX ImmunityBioBiotechnologySEC FORM 4 Code M$897300 at $2.99filing
30 Jun 2026filed 1 Jul 2026IBRX ImmunityBioBiotechnologySEC FORM 4 Sold$9,0001,000 at $9.00filing

Sectors

Health Care6

Buys in green, sells in red, by the company’s sector.

Related people

Cheryl CohenDirector · Director at ImmunityBio, filing Form 4 there in the last year
Barry J. SimonDirector · Director at ImmunityBio, filing Form 4 there in the last year
Wesley ClarkDirector · Director at ImmunityBio, filing Form 4 there in the last year
Bruce WendelDirector · Director at ImmunityBio, filing Form 4 there in the last year
Michael D. BlaszykDirector · Director at ImmunityBio, filing Form 4 there in the last year
Lisa C. McClainRepresentative, MI-09 · Also traded IBRX in the last 90 days